CEO Michael Kauffman sold $206K of Karyopharm Therapeutics Inc.

Sold$205,518

$15.52Price

13,243Shares

−1%Stake

What KPTI did after the filing

Prices for KPTI after this filing aren't in yet.

Traded Thu, Feb 11. Filed Wed, Feb 17, 1:44 PM ET, during the session. Not investment advice.